EDGAR Filing Documents for 0001193125-08-259540

Form 8-K - Current report:

SEC Accession No. 0001193125-08-259540

Filing Date

2008-12-23

Accepted

2008-12-23 16:01:33

Documents

Period of Report

2008-12-17

Items

Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 8-K	d8k.htm	8-K	23401
2	AMENDED AND RESTATED EMPLOYMENT AGREEMENT WITH JEAN-JACQUES BIENAIME	dex101.htm	EX-10.1	57450
3	AMENDED AND RESTATED EMPLOYMENT AGREEMENT WITH STEPHEN ASELAGE	dex102.htm	EX-10.2	33192
4	AMENDED AND RESTATED EMPLOYMENT AGREEMENT WITH ROBERT A. BAFFI	dex103.htm	EX-10.3	33182
5	AMENDED AND RESTATED EMPLOYMENT AGREEMENT WITH EMIL D. KAKKIS, M.D., PH.D.	dex104.htm	EX-10.4	33664
6	AMENDED AND RESTATED EMPLOYMENT AGREEMENT WITH JEFFREY H. COOPER	dex105.htm	EX-10.5	33080
7	AMENDED AND RESTATED EMPLOYMENT AGREEMENT WITH G. ERIC DAVIS	dex106.htm	EX-10.6	33016
8	AMENDED AND RESTATED EMPLOYMENT AGREEMENT WITH MARK WOOD	dex107.htm	EX-10.7	32995
9	NONQUALIFIED DEFERRED COMPENSATION PLAN	dex108.htm	EX-10.8	140598
10	2009 TECHNICAL AMENDMENT TO SHARE INCENTIVE PLAN	dex109.htm	EX-10.9	11812
	Complete submission text file	0001193125-08-259540.txt		433943

Mailing Address 105 DIGITAL DRIVE NOVATO CA 94949

Business Address 105 DIGITAL DRIVE NOVATO CA 94949 4155066700

BIOMARIN PHARMACEUTICAL INC (Filer) CIK: 0001048477 (see all company filings)